Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Daptacel, Sanofi)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDiphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Daptacel, Sanofi)
Drug Alias Name白喉、破伤风类毒素和无细胞百日咳吸附疫苗 - 赛诺菲DTaP-vaccine - sanofi-pasteurTripacelDaptacel
ClassificationVaccines > Biological material > Toxoid vaccineVaccines > Vaccine type > Combination vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPoliomyelitisTetanusDiphtheria +[5] 
Global Approved IndicationsTetanusDiphtheriaWhooping Cough
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2002/05/14
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiSanofi Pasteur
Active IndicationsTetanusDiphtheriaWhooping Cough
Inactive IndicationsPoliomyelitisHaemophilus Infections

Other Information

ATC CodeJ07AJ52
Related LinksN/A